首页> 外文期刊>Expert Review of Molecular Diagnostics >B-type natriuretic peptides: prognostic markers in stable coronary artery disease
【24h】

B-type natriuretic peptides: prognostic markers in stable coronary artery disease

机译:B型利钠肽:稳定冠状动脉疾病的预后标志物

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Circulating concentrations of B-type natriuretic peptide (BNP) and the N-terminal fragmentn(NT) of its prohormone (proBNP) are related to cardiac function and have emerged as clinicallynuseful tools for the diagnosis of heart failure and for the estimation of prognosis in patientsnwith heart failure and acute coronary syndromes. Recent studies have also convincinglyndocumented that both BNP and NT-proBNP are powerful, independent prognostic indicators innpatients with stable coronary artery disease. The associations are strongest for the end-pointsnof death and heart failure, whereas the association with cardiac ischemic events is weaker ornnonexistent, after adjustment for confounding factors. Importantly, BNP and NT-proBNPnappear to provide incremental prognostic information to conventional risk factors, includingnmarkers of ventricular function and ischemia. Data documenting that BNP or NT-proBNPnmeasurements can be used to guide treatment decisions in patients with stable coronarynartery disease are still lacking.
机译:B型利尿钠肽(BNP)及其激素原(proBNP)的N端片段(NT)的循环浓度与心功能有关,已成为诊断心力衰竭和评估预后的临床有用工具心力衰竭和急性冠状动脉综合征的患者。最近的研究也令人信服地证明,BNP和NT-proBNP都是稳定冠心病患者的有力,独立的预后指标。调整混杂因素后,死亡和心力衰竭的终点之间的关联最强,而与心肌缺血事件的关联更弱。重要的是,BNP和NT-proBNP似乎可以为常规危险因素(包括心室功能和局部缺血的标志物)提供更多的预后信息。尚缺乏证明BNP或NT-proBNPn测量可用于指导稳定冠状动脉疾病患者的治疗决策的数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号